Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease

Rachel Halpern1, Christine L Baker2, Jun Su3, Kimberly B Woodruff2, Ryne Paulose-Ram2, Victoria Porter1, Hemal Shah41Health Economics and Outcomes Research, OptumInsight, Eden Prairie, MN, USA; 2Global Market Access, Primary Care Business Unit, Pfizer Inc, New York, NY, USA; 3Health Economics and Ou...

Full description

Bibliographic Details
Main Authors:	Halpern R, Baker CL, Su J, Woodruff KB, Paulose-Ram R, Porter V, Shah H
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-07-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/outcomes-associated-with-initiation-of-tiotropium-or-fluticasonesalmet-a7948

Similar Items

Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease
by: Chatterjee Arjun, et al.
Published: (2012-02-01)

Superiority of tiotropium plus olodaterol in comparison with salmeterol plus fluticasone
by: Tamura T, et al.
Published: (2016-11-01)

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
by: Anzueto AR, et al.
Published: (2017-05-01)

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
by: Shalini Naik, et al.
Published: (2010-03-01)

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
by: Hideki Yasui, et al.
Published: (2018-05-01)

Effect of combined application of tiotropium and Salmeterol and fluticasone propionate powder on disease control in stable COPD patients
by: Xiu-Ping Han, et al.
Published: (2016-06-01)

The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD
by: Henrik Watz, et al.
Published: (2020-05-01)

Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?
by: Keiichiro eAkamatsu, et al.
Published: (2011-07-01)

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
by: Kalhan R, et al.
Published: (2021-04-01)

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
by: An, et al.
Published: (2010-12-01)

Effect of tiotropium bromide combined with salmeterol fluticasone inhalation on airway function and airway inflammation in patients with moderate-severe stable COPD
by: Min Xiang
Published: (2016-12-01)

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
by: Anderson Julie A, et al.
Published: (2009-06-01)

Cost-effectiveness analysis of tiotropium bromide and salmeterol in the treatment of severe chronic opstructive pulmonary disease
by: Stojanović Stefan
Published: (2012-01-01)

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study
by: Moretz C, et al.
Published: (2019-08-01)

Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study
by: Kaplan A, et al.
Published: (2019-01-01)

Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease
by: Asai K, et al.
Published: (2015-04-01)

Tiotropium and the Treatment of Chronic Obstructive Pulmonary Disease
by: Nick R Anthonisen
Published: (2007-01-01)

Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
by: Yoxall Sally, et al.
Published: (2007-07-01)

Fluticasone/salmeterol reduces remodelling and neutrophilic inflammation in severe equine asthma
by: Michela Bullone, et al.
Published: (2017-08-01)

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
by: Barbara P Yawn, et al.
Published: (2010-06-01)

Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
by: Beatrix Balint, et al.
Published: (2010-09-01)

Current trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone
by: Robyn Teply, et al.
Published: (2010-03-01)

Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01)

Computerized Tomography Image Feature under Convolutional Neural Network Algorithm Evaluated for Therapeutic Effect of Clarithromycin Combined with Salmeterol/Fluticasone on Chronic Obstructive Pulmonary Disease
by: Guoping Luo, et al.
Published: (2021-01-01)

Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978]
by: Ramesh Warren, et al.
Published: (2006-02-01)

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
by: Xiaofen Jin, et al.
Published: (2020-01-01)

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy
by: Moretz C, et al.
Published: (2020-10-01)

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
by: Nina Maria Ainali, et al.
Published: (2020-08-01)

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)
by: Beeh KM, et al.
Published: (2016-02-01)

Tiotropium bromide: role in the treatment of chronic obstructive pulmonary disease
by: A I Sinopalnikov
Published: (2004-03-01)

Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
by: Stanford RH, et al.
Published: (2012-12-01)

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD
by: Martyn R. Partridge, et al.
Published: (2009-08-01)

Efficacy of Budesonide in Combination with Formoterol in Patients with Inadequately Controlled Asthma on Fluticasone in Combination with Salmeterol
by: Yoshihiro Kanemitsu, et al.
Published: (2012-01-01)

Effects of Salmeterol Xinafoate and Fluticasone Propionate on Immunological Activation of Human Cultured Mast Cells
by: Hirotomo Akabane, et al.
Published: (2006-01-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk
by: Covelli H, et al.
Published: (2015-12-01)

Cost-effectiveness of combination fluticasone propionate&ndash;salmeterol 250/50 &mu;g versus salmeterol in severe COPD patients
by: An, et al.
Published: (2010-06-01)

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients
by: Brooks J, et al.
Published: (2012-03-01)

Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database
by: Miller DP, et al.
Published: (2011-09-01)

Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations
by: Kai-Michael Beeh, et al.
Published: (2009-02-01)